AMORYN Means Happiness
Real People, Real Success
Response Rate of AMORYN Users with Depression, Anxiety or Panic After Six Weeks

Introduction
Ultimately, real-world results matter most. In order to measure the real-world rate of response to supplementation with AMORYN, BioNeurix Corp. surveyed a random sample of individuals who had started using AMORYN approximately six to eight weeks prior. Our informal surveys demonstrate that AMORYN achieves an extraordinary success rate. After taking AMORYN for six weeks or more, over 80% of AMORYN users report positive results. Of users with depression, 90% reported that AMORYN reduced the severity of their depression. For those with anxiety, 88% reported a reduction in feelings of anxiety. For users with panic attacks, 88% told us they were having fewer panic attacks and 87% responded that any remaining panic attacks were less severe.

Data Collection
The results shown here were collected through informal surveys of AMORYN users. We randomly selected and e-mailed customers, all of which had purchased AMORYN between six and eight weeks prior, and requested that they participate in a brief survey about their experience with the supplement. Both individuals that were still using the supplement and those that had discontinued use for any reason (due to side effects, for instance) were included. The 66 AMORYN users that chose to participate completed a brief online questionnaire. The respondents were not compensated in any way, and the identities of the respondents were not revealed to the researchers compiling the data. The figures shown in the graphs below were compiled on April 25, 2005, and represent the results of the most recent survey. Past surveys involving a total of over 300 AMORYN users have produced consistent results.

Please keep in mind that this data does not represent the results of a controlled clinical trial and should not be considered scientific proof of AMORYN's effectiveness. (For this, please review the clinical trials demonstrating the effectiveness of AMORYN's main ingredient.) This information is intended solely to give you a better idea of what current AMORYN users think about the supplement.


After taking AMORYN for six weeks, 90% of AMORYN users report feeling less depressed and 88% report feeling less anxious.
Fig. 1: Reported Effect of AMORYN on Severity of Various Negative Emotions

82% of AMORYN users report a positive overall experience with the supplement.
Fig. 2: Reported Overall Rating of Experience (Positive or Negative) with AMORYN After 6-8 Weeks

Of those AMORYN users who have previously taken prescription medications for depression, 54% rate AMORYN superior to antidepressant drugs and 27% rate AMORYN comparable to antidepressant drugs.
Fig. 3: User Opinions of AMORYN vs. Antidepressant Drugs

Of those AMORYN users who have previously taken other supplements containing St. John's Wort extract, 76% rate AMORYN superior to other St. John's Wort products.
Fig. 4: User Opinions of AMORYN vs. other St. John's Wort Brands

View Fig. 5: Side Effect Frequency and Severity As Reported by AMORYN Users in First 6-8 Weeks

Discussion
No single factor is wholly responsible for AMORYN's unsurpassed degree of real-world effectiveness. Rather, a number of considerations contribute to the consistently positive responses reported by AMORYN users:
  • emphasizing extensive clinical research over pseudo-science or anecdotal evidence during formula design
  • adhering to strict rigorous quality-control standards during manufacture
  • including an ultra-potent St. John's Wort extract that contains a high concentration of hyperforin, a compound that's clinically-proven to relieve depression as or more effectively than drugs such as Paxil® and Prozac®
  • delivering nutrients such as B vitamins, selenium, and vitamin D to reverse mood-related deficiencies
  • providing a broad spectrum of balanced emotional support by acting upon multiple mood-related pathways at multiple levels of function
  • including all ingredients in the proper, active, clinically-supported doses (unlike nearly every other mood supplement)
  • packaging in amber bottles and storing in a climate-controlled warehouse to prevent breakdown of the ingredients
  • assigning every customer a Personal Wellness Consultant to provide comprehensive follow-up support

    Conclusion
    The data shown above demonstrates that the vast majority of AMORYN users feel that the supplement has improved their mood and lessened feelings of depression and/or anxiety. These extraordinary success rates truly set AMORYN apart from the alternatives, making it a natural supplement that actually delivers on its promises. Although no therapy works for every individual, there's an excellent chance that you can benefit from AMORYN. Order today to experience the mood-elevating effects of AMORYN, the most effective supplement available for sustained emotional support.

    Further Reading
    Please read the testimonials to learn more about the specific benefits experienced by some of these individuals, or review the controlled clinical research demonstrating the effectiveness of hyperforin, the main ingredient. Otherwise, you can order now to begin experiencing the benefits of AMORYN for yourself.



    The terms "depression", "anxiety" and "panic" found above refer to common emotions, not medically-recognized psychiatric conditions. AMORYN should not be considered a treatment for major depressive disorder, generalized anxiety disorder, panic disorder, or any other disease. The information provided above is intended to illustrate the opinions of some AMORYN users and should not be considered scientifically-valid proof of AMORYN's therapeutic efficacy or used to guide medical treatment. Individual results will vary.
  • ORDERSCIENTIFIC RESEARCHSUCCESS RATESTESTIMONIALSSAFETY FACTSQUALITY CONTROLFAQ (FREQUENTLY ASKED QUESTIONS)CONTACT US
    ©2005-2008 BioNeurix Corp. | About Us | Privacy and Security | Terms and Conditions of Sale | Contact Us | Site Map

    AMORYN is not a drug and is not intended to diagnose, treat, cure or prevent major depressive disorder, bipolar disorder, dysthymic disorder, generalized anxiety disorder, panic disorder, or any other disease. AMORYN should not be considered equivalent to or a substitute for an FDA-approved drug. AMORYN and its logo are trademarks of BioNeurix Corp.
    Placing an order indicates that you understand and agree to the Terms and Conditions of Sale.

    The statements on the amoryn.com website have not been evaluated by the Food and Drug Administration. AMORYN is a dietary supplement, not a drug. AMORYN is not intended to diagnose, treat, cure or prevent any disease.